DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20194802

Prescription analysis of hypolipidaemic agents in the department of cardiology in a tertiary care hospital

Manju Gari, Megha Bansal

Abstract


ABSTRACT

Background: The objective of the present study was to evaluate the prescribing pattern of hypolipidaemic drugs in the outpatient department of cardiology in a tertiary care hospital.

Methods: A cross-sectional study was conducted in the department of cardiology for the period of 3 months. A total of 526 prescriptions were analyzed for variants such as the disease patterns, the type of hypolipidaemic drugs which are prescribed for those diseases, the prescribing daily dose of the hypolipidaemic drugs and the prescribing daily dose/daily defined dose ratio of the drugs.

Results: On evaluation of the prescriptions, it was conferred that both the patients of normal lipid profile (34.77%) and abnormal lipid profile (65.18%) were prescribed hypolipidaemic drug. Diabetes with hypertension (35.74%) was the most common disease for which hypolipidaemic drugs were prescribed. Atorvastatin (30.98%) was the most common drug which was prescribed as monotherapy, whereas atorvastatin with aspirin and clopidogrel (17.49%) was the most common drug prescribed in combination.

Conclusions: Use of statin has become very prevalent with increasing trends of use in both normal and abnormal lipid profile patients, suggesting consideration of rational use of statins to follow good prescribing pattern so that morbidity and mortality can be prevented.


Keywords


Statins, Hypolipidaemic agents, Prescribing pattern

Full Text:

PDF

References


Pencina MJ, Navar-Boggan AM, D’Agostino RB, Williams K, Neely B, Sniderman AD, et al. Application of new cholesterol guidelines to a population-based sample. N Engl J Med. 2014;370:1422-31.

Goff DC, Lloyd-Jones DM, Bennett G, Coady S, D’Agostino RB, Gibbons R, et al. 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:S49-73.

2018 Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J AM Coll Cardiol. 2018; 10.

Pankaj G, Sharma G, Baljinderpal S, Singh J, Singh J, Randhawa GK, et al. Prospective, non- interventional, uncontrolled, open chart, pharmaco-epidemiologic study of prescribing patterns for lipid-lowering drugs at a tertiary care teaching hospital in North India. Clinical Therapeutics. 2002;24(12):2064-76.

Gupta R, Mohan I, Narula J. Trends in coronary heart disease epidemiology in India. Annals of Global Health. 2016;82(2):307-15.

Geldsetzer P, Manne-Goehler J, Theilmann M, Davies JI, Awasthi A, Vollmer S, et al. Diabetes and Hypertension in India: A Nationally Representative Study of 1.3 Million Adults. JAMA Internal Med. 2018;178(3):363-72.

Lim SP. Role of statins in Coronary artery Disease. Chonnam Med J. 2013;49(1):1-6.

Iain LO. Principles of prescription order writing and patient compliance. In: Brunton L, Chabner B, Knollman B. Goodman and Gilman’s The Pharmacological basis of Therapeutics. 12th ed. USA: McGraw Hill; 2011: 1879.

Safe prescribing. Available at: http://www.gmcuk. org/guidance/ethical_guidance/14316.asp. Accessed on 11 September 2019.

ATC Classification. Available at: https://www.who. int/medicines/regulation/medicines-safety/toolkit_atc /en/. Accessed on 11 September 2019.